Introduction Dengue fever is severe vector-borne infectious disease transmitted by mosquitoes carrying the dengue virus. Outbreaks arise in various countries annually, posing a significant challenge to global public health. Mathematical models have become invaluable tools for grasping the transmission dynamics and behavior of diseases 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 . For instance, Li et al. 1 explored a reaction-diffusion dengue model that incorporated both wild and Wolbachia-infected mosquito populations, assessing their dynamics and control measures. Xu and Zhao 3 devised a model for dengue transmission, examining the stability of both disease-free and endemic states. Zhu et al. 5 introduced a dengue model with a free boundary and derived conditions under which the disease either disappears or spreads. Similarly, Fang et al. 7 took into account a time-space periodic environment, determining the correlation between the speeds of almost pulsating waves and disease spread. Chang et al. 9 crafted a diffusion model for dengue influenced by lévy noise, outlining the conditions for near-optimal controls. Zhu et al. 11 evaluated a dengue model with nonlocal incidence and free boundaries, ascertaining conditions for the disease’s disappearance or proliferation. A critical observation from the above literature is their reliance on reaction-diffusion models, where the Laplace operator essentially governs the localized random diffusion behavior at nearby spatial locations. However, human movement is not always limited to adjacent areas, indicating that the Laplacian operator based reaction-diffusion model might fall short in depicting long range disease transmission effects 12 . For a more accurate representation of movement between distant locations, our study introduces nonlocal diffusion, where the diffusion process is characterized using integral operators ( \(\int _{\Omega }{\mathcal {J}}(x-y)\varphi (y)dy-\varphi (x)\) ) 13 , where \({\mathcal {J}}(\cdot )\) is an even function with probability density one, \({\mathcal {J}}(x-y)\) represents the probability of jumping from position y to position x and \({\mathcal {J}}(x-y)\varphi (y)dy\) denotes the rate at which individuals reach the position x from other positions. For more on nonlocal diffusion, readers can refer to existing literature 14 , 15 , 16 , 17 , 18 , 19 , 20 . The main objectives of this study are: (1) constructing a nonlocal diffusion dengue model. Using the Fréchet differentiability and semigroups theory, we validate the solution’s existence, uniqueness, and boundedness. (2) Using the eigenvalue problem of the nonlocal diffusion term and constructing a Lyapunov function, we prove the model’s global stability and uniform persistence. (3) Through numerical simulations, we discuss the global stability and consistent persistence of the disease are. When the disease persists, we analyze the diffusion impact on infected humans and mosquitoes. This study unfolds as follows: In “ Model and preliminaries ” section, we present the model and subsequently prove the existence, uniqueness, positiveity, and boundedness of solutions. Using the next-generation operator, we define the basic reproduction number. “ Global stability and uniform persistence ” section focuses on proving the global asymptotic stability and uniform persistence of the system, achieved through the construction of Lyapunov functions and the application of the comparison principle. “ Numerical simulations ” section provides numerical simulations. Finally, “ Conclusions ” section concludes the article. Model and preliminaries To assess the impact of nonlocal diffusion on the dengue model, we begin by introducing the SIR-SI model detailed in 21 , the parameters are defined in Table 1 . $$\begin{aligned} {\left\{ \begin{array}{ll} \frac{d S_{H}}{dt}=\mu _{h}N_{H}-\mu S_{H}-\frac{\beta _{H}b}{N_{H}+m}S_{H}I_{V},\\ \frac{d I_{H}}{dt}=\frac{\beta _{H}b}{N_{H}+m}S_{H}I_{V}-(\mu +\gamma _{H})I_{H}, \\ \frac{d R_{H}}{dt}=\gamma _{H}I_{H}-\mu R_{H},\\ \frac{d S_{V}}{dt}=A-\nu S_{V}-\frac{\beta _{V}b}{N_{H}+m}S_{V}I_{H},\\ \frac{d I_{V}}{dt}=\frac{\beta _{V}b}{N_{H}+m}S_{V}I_{H}-\nu I_{V}, \\ \end{array}\right. } \end{aligned}$$ (1) Table 1 Definitions of all parameters. Full size table It’s worth noting that mosquitoes generally have a limited, activity range, typically flying only tens to hundreds of meters. The furthest recorded flight distance is one to two kilometers. Given this, the nonlocal spread of mosquitoes was disregarded. Also, since the third equation doesn’t feature in the other equations of system ( 1 ), we focus on the subsequent dengue model: $$\begin{aligned} {\left\{ \begin{array}{ll} \frac{\partial S_{H}}{\partial t}=d_{1}\int _{\Omega }{\mathcal {J}}(x-y)S_{H}(y,t)dy-d_{1}S_{H}(x,t)+\mu _{h}(x)N_{H}-\mu (x) S_{H}(x,t)-\frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t),\\ \frac{\partial I_{H}}{\partial t}=d_{2}\int _{\Omega }{\mathcal {J}}(x-y)I_{H}(y,t)dy-d_{2}I_{H}(x,t)+\frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t)-(\mu (x)+\gamma _{H}(x))I_{H}(x,t), \\ \frac{\partial S_{V}}{\partial t}=A(x)-\nu (x) S_{V}(x,t)-\frac{\beta _{V}(x)b(x)}{N_{H}+m}S_{V}(x,t)I_{H}(x,t),\\ \frac{\partial I_{V}}{\partial t}=\frac{\beta _{V}(x)b(x)}{N_{H}+m}S_{V}(x,t)I_{H}(x,t)-\nu (x) I_{V}(x,t),\\ S_{H}(x,0)=S_{H,0}(x), I_{H}(x,0)=I_{H,0}(x), S_{V}(x,0)=S_{V,0}(x) I_{V}(x,0)=I_{V,0}(x),\\ x\in \Omega ,~~t>0, \\ \end{array}\right. } \end{aligned}$$ (2) with Neumann boundary condition (the derivative is zero when x is at the boundary) $$\begin{aligned} \frac{\partial S_{H}}{\partial \nu }=\frac{\partial I_{H}}{\partial \nu }=\frac{\partial S_{V}}{\partial \nu }=\frac{\partial I_{V}}{\partial \nu }=0,~ x\in \partial \Omega ,~ t>0, \end{aligned}$$ (3) and initial condition $$\begin{aligned} S_{H}(x,0)=S_{H,0}(x), I_{H}(x,0)=I_{H,0}(x), S_{V}(x,0)=S_{V,0}(x), I_{V}(x,0)=I_{V,0}(x), x\in \Omega . \end{aligned}$$ (4) where Eq. ( 4 ) represents the value in the individual at the initial time (namely, t=0). \(d_{1}\) and \(d_{2}\) represent the diffusion coefficients, and \(d_{1}>0\) , \(d_{2}>0\) . \(\mu _{h}(x)\) , \(\mu (x)\) , \(\beta _{H}(x)\) , b ( x ), \(\gamma _{H}(x)\) , \(\beta _{v}(x)\) and \(\nu (x)\) are positive continuous functions on \({\overline{\Omega }}\) . The dispersal kernel function \({\mathcal {J}}\) is continuous and satisfies the following properties $$\begin{aligned} {\mathcal {J}}(0)>0,~\int _{R}{\mathcal {J}}(x)dx=1,~{\mathcal {J}} (x)>0~on~{\overline{\Omega }},~{\mathcal {J}}(x)={\mathcal {J}}(-x)\ge 0~on~R. \end{aligned}$$ (5) Let us consider the following function spaces and positive cones. $$\begin{aligned} \mathbb {X}:=C({\overline{\Omega }}),~\mathbb {X}_{+}:=\mathbb {C}_{+}({\overline{\Omega }}),~\mathbb {Y}:=\mathbb {C}({\overline{\Omega }})\times \mathbb {C}({\overline{\Omega }})\times \mathbb {C}({\overline{\Omega }})\times \mathbb {C}({\overline{\Omega }}),~\mathbb {Y}_{+}:=\mathbb {C}_{+}({\overline{\Omega }})\times \mathbb {C}_{+}({\overline{\Omega }})\times \mathbb {C}_{+}({\overline{\Omega }})\times \mathbb {C}_{+}({\overline{\Omega }}). \end{aligned}$$ \(\mathbb {X}\) and \(\mathbb {Y}\) are defined as follows, respectively. \(\Vert \chi \Vert _{\mathbb {X}}:=\sup _{x\in {\overline{\Omega }}}|\chi (x)|,~\chi \in \mathbb {X},\) $$\begin{aligned} \Vert (g_{1},g_{2},g_{3},g_{4})\Vert _{\mathbb {Y}}:=\sup _{x\in {\overline{\Omega }}}\sqrt{|g_{1}(x)|^{2}+|g_{2}(x)|^{2} +|g_{3}(x))|^{2}+|g_{4}(x))|^{2}},\\ ~(a_{1},a_{2},a_{3},a_{4})\in \mathbb {Y}. \end{aligned}$$ Next, we define the linear operators on \(\mathbb {X}\) . $$\begin{aligned} \begin{aligned}{}&{\mathcal {A}}_{1}\chi _{1}(x):=d_{1}\int _{\Omega } {\mathcal {J}}(x-y)\chi _{1}(y)dy-d_{1}\chi _{1}(x)-\mu (x)\chi _{1}(x),\\&{\mathcal {A}}_{2}\chi _{2}(x):=d_{2}\int _{\Omega } {\mathcal {J}}(x-y)\chi _{2}(y)dy-d_{2}\chi _{2}(x)-(\mu (x)+\gamma _{H}(x))\chi _{2}(x),\\&{\mathcal {A}}_{3}\chi _{3}(x):=-\nu (x)\chi _{3}(x),\\&{\mathcal {A}}_{4}\chi _{4}(x):=-\nu (x)\chi _{4}(x). \end{aligned} \end{aligned}$$ (6) From the above, we know that \({\mathcal {A}}_{i} (i=1,2,3,4)\) are bounded linear operators, by virtue of 22 , Theorem 1.2, we obtain that \({{\mathcal {A}}_{i}(t)}_{t\ge 0}\) are uniformly continuous semigroups on \(\mathbb {X}\) . Furthermore, according to 23 , Sect. 2.1.1, the semigroups \({{\mathcal {A}}_{i}(t)}_{t\ge 0}\) are positive. Well-posedness of the solution In this section, we will prove the existence and uniqueness of the solution for system ( 2 ). Theorem 2.1 Assuming \((S_{H,0},I_{H,0},S_{V,0}I_{V,0})\in \mathbb {Y}\) , system ( 2 ) exists the unique solution \((S_{H}(\cdot ,t),I_{H}(\cdot ,t), S_{V}(\cdot ,t)I_{V}(\cdot ,t))\) for all \(t\in [0,t_{0})\) , and either \(t_{0}=+\infty \) or \(\limsup _{t\rightarrow t_{0_{-0}}}\Vert (S_{H}(\cdot ,t),I_{H}(\cdot ,t),S_{V}(\cdot ,t),I_{V}(\cdot ,t)\Vert =+\infty \) . Proof $$\begin{aligned} \mathbb {F}(\vartheta _{1},\vartheta _{2},\vartheta _{3},\vartheta _{4})(x) =\left( {\begin{array}{*{10}{c}} \mu _{h}(x)N_{H}-\frac{\beta _{H}(x)b(x)}{N_{H}+m}\vartheta _{1}\vartheta _{4}\\ \frac{\beta _{H}(x)b(x)}{N_{H}+m}\vartheta _{1}\vartheta _{4}\\ A-\frac{\beta _{V}(x)b(x)}{N_{H}+m}\vartheta _{2}\vartheta _{3}\\ \frac{\beta _{V}(x)b(x)}{N_{H}+m}\vartheta _{2}\vartheta _{3}\\ \end{array}}\right) . \end{aligned}$$ Let \(\mathbb {F}'[\zeta _{1},\zeta _{2},\zeta _{3},\zeta _{4}]\) be a linear operator on \(\mathbb {Y}\) defined as follow: $$\begin{aligned} \mathbb {F}'[\zeta _{1},\zeta _{2},\zeta _{3},\zeta _{4}](\vartheta _{1}, \vartheta _{2},\vartheta _{3},\vartheta _{4})(x)=\left( {\begin{array}{*{10}{c}} -\frac{\beta _{H}(x)b(x)}{N_{H}+m}\zeta _{4}\vartheta _{1} -\frac{\beta _{H}(x)b(x)}{N_{H}+m}\zeta _{1}\vartheta _{4}\\ \frac{\beta _{H}(x)b(x)}{N_{H}+m}\zeta _{4}\vartheta _{1} +\frac{\beta _{H}(x)b(x)}{N_{H}+m}\zeta _{1}\vartheta _{4}\\ -\frac{\beta _{V}(x)b(x)}{N_{H}+m}\zeta _{3}\vartheta _{2} -\frac{\beta _{V}(x)b(x)}{N_{H}+m}\zeta _{2}\vartheta _{3}\\ \frac{\beta _{V}(x)b(x)}{N_{H}+m}\zeta _{3}\vartheta _{2} +\frac{\beta _{V}(x)b(x)}{N_{H}+m}\zeta _{2}\vartheta _{3}\\ \end{array}}\right) . \end{aligned}$$ By calculating, we have $$\begin{aligned} \begin{aligned} \mathbb {F}(\vartheta _{1},\vartheta _{2},\vartheta _{3},\vartheta _{4})(x)&=\mathbb {F}(\zeta _{1},\zeta _{2},\zeta _{3},\zeta _{4})(x) +\mathbb {F}'[\zeta _{1},\zeta _{2},\zeta _{3},\zeta _{4}](\vartheta _{1} -\zeta _{1},\vartheta _{2}-\zeta _{2},\vartheta _{3}-\zeta _{3},\vartheta _{4}-\zeta _{4})(x)\\&\quad +\left( {\begin{array}{*{10}{c}} -\frac{\beta _{H}(x)b(x)}{N_{H}+m}(\vartheta _{1}-\zeta _{1})(\vartheta _{4}-\zeta _{4})\\ \frac{\beta _{H}(x)b(x)}{N_{H}+m}(\vartheta _{1}-\zeta _{1})(\vartheta _{4}-\zeta _{4})\\ -\frac{\beta _{V}(x)b(x)}{N_{H}+m}(\vartheta _{2}-\zeta _{2})(\vartheta _{3}-\zeta _{3})\\ \frac{\beta _{V}(x)b(x)}{N_{H}+m}(\vartheta _{2}-\zeta _{2})(\vartheta _{3}-\zeta _{3})\\ \end{array}}\right) , \end{aligned} \end{aligned}$$ due to the coefficients are positive and bounded, we have that the last term in the right-hand of this equation is \(o\{(\vartheta _{1},\vartheta _{2},\vartheta _{3}, \vartheta _{4})^{T}-(\zeta _{1},\zeta _{2},\zeta _{3},\zeta _{4})^{T}\}\) . It means that \(\mathbb {F}\) is Fréchet differentiable for \((\zeta _{1},\zeta _{2},\zeta _{3},\zeta _{4})^{T}\) on \(\mathbb {Y}\) . Moreover, we have $$\begin{aligned} \begin{aligned}{}&\Vert \mathbb {F}'[\zeta _{1},\zeta _{2},\zeta _{3},\zeta _{4}] -\mathbb {F}'[{\tilde{\zeta }}_{1},{\tilde{\zeta }}_{2},{\tilde{\zeta }}_{3},{\tilde{\zeta }}_{4}]\Vert \\&\quad =\sup _{\Vert (\vartheta _{1},\vartheta _{2},\vartheta _{3}, \vartheta _{4})^{T}\Vert _{\mathbb {Y}}\le 1}\Vert \{\mathbb {F}' [\zeta _{1},\zeta _{2},\zeta _{3},\zeta _{4}]-\mathbb {F}'[{\tilde{\zeta }}_{1}, {\tilde{\zeta }}_{2},{\tilde{\zeta }}_{3},{\tilde{\zeta }}_{4}]\}(\vartheta _{1}, \vartheta _{2},\vartheta _{3},\vartheta _{4})\Vert _{\mathbb {Y}}\\&\quad =\sup _{\Vert (\vartheta _{1},\vartheta _{2},\vartheta _{3}, \vartheta _{4})^{T}\Vert _{\mathbb {Y}}\le 1}\Vert \{-\frac{\beta _{H}(x)b(x)}{N_{H}+m} (\zeta _{4}-{\tilde{\zeta }}_{4})\vartheta _{1}-\frac{\beta _{H}(x)b(x)}{N_{H}+m} (\zeta _{1}-{\tilde{\zeta }}_{1})\vartheta _{4},\\&\quad \quad \quad \frac{\beta _{H}(x)b(x)}{N_{H}+m}(\zeta _{4}-{\tilde{\zeta }}_{4})\vartheta _{1} +\frac{\beta _{H}(x)b(x)}{N_{H}+m}(\zeta _{1}-{\tilde{\zeta }}_{1})\vartheta _{4}, -\frac{\beta _{V}(x)b(x)}{N_{H}+m}(\zeta _{3}-{\tilde{\zeta }}_{3})\vartheta _{2}\\&\quad \quad -\frac{\beta _{V}(x)b(x)}{N_{H}+m}(\zeta _{2}-{\tilde{\zeta }}_{2})\vartheta _{3},\frac{\beta _{V}(x)b(x)}{N_{H}+m}(\zeta _{3}-{\tilde{\zeta }}_{3})\vartheta _{2} +\frac{\beta _{V}(x)b(x)}{N_{H}+m}(\zeta _{2}-{\tilde{\zeta }}_{2})\vartheta _{3}\}\Vert \\&\quad \le 2\frac{{\bar{\beta }}_{H}{\bar{b}}}{N_{H}+m}\Vert (\zeta _{1}-{\tilde{\zeta }}_{1}, \zeta _{2}-{\tilde{\zeta }}_{2},\zeta _{3}-{\tilde{\zeta }}_{3},\zeta _{4}-{\tilde{\zeta }}_{4})^{T}\Vert _{\mathbb {Y}}, \end{aligned} \end{aligned}$$ where \(({\tilde{\zeta }}_{1},{\tilde{\zeta }}_{2},{\tilde{\zeta }}_{3},{\tilde{\zeta }}_{4})^{T}\in \mathbb {Y}\) , this implies that \(\mathbb {F}\) is continuously Fr \(\acute{e}\) chet differentiable 24 , Lemma 3.1 on \(\mathbb {Y}\) . Due to \({{\mathcal {A}}_{i}(t)}_{t\ge 0}\) are uniformly continuous semigroups, the solution \((S_{H}(x,t),I_{H}(x,t),S_{V}(x,t)I_{V}(x,t))\) of system ( 2 ) can be written as follows: $$\begin{aligned} p(x,t)=e^{{\mathcal {A}}(t)}p(\cdot ,t)(x)+\int _{0}^{t} E^{{\mathcal {A}}(t-s)}\mathbb {F}(w(\cdot ,\tau ))(x)ds,~t\ge 0,~x\in {\bar{\Omega }}, \end{aligned}$$ where $$\begin{aligned} p(x,t)=\left( {\begin{array}{*{10}{c}} S_{H}(x,t)\\ I_{H}(x,t)\\ S_{V}(x,t)\\ I_{V}(x,t)\\ \end{array}}\right) ,~~ {\mathcal {A}}(t)=\left( {\begin{array}{*{10}{c}} {\mathcal {A}}_{1}(t)\\ {\mathcal {A}}_{2}(t)\\ {\mathcal {A}}_{3}(t)\\ {\mathcal {A}}_{4}(t)\\ \end{array}}\right) ,~~ \mathbb {F}(p(x,t))=\left( {\begin{array}{*{10}{c}} \mu _{h}(x)N_{H}-\frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t)\\ \frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t)\\ A-\frac{\beta _{V}(x)b(x)}{N_{H}+m}S_{V}(x,t)I_{H}(x,t)\\ \frac{\beta _{V}(x)b(x)}{N_{H}+m}S_{V}(x,t)I_{H}(x,t)\\ \end{array}}\right) . \end{aligned}$$ Due to \({\mathcal {A}}\) be the infinitesimal generator of \({e^{t{\mathcal {A}}}}_{t\ge 0}\) and \(\mathbb {F}\) is continuously Fr \(\acute{e}\) chet differentiable on \(\mathbb {Y}\) . From 25 , Proposition 4.16, the result holds. \(\square \) Lemma 2.1 If \((S_{H}(\cdot ,t),I_{H}(\cdot ,t),S_{V}(\cdot ,t)I_{V}(\cdot ,t))\in \mathbb {Y}\) be the solution of system ( 2 ) with \((S_{H,0},I_{H,0},S_{V,0}I_{V,0})\in \mathbb {Y}_{+}\) . Then \((S_{H}(\cdot ,t),I_{H}(\cdot ,t),S_{V}(\cdot ,t)I_{V}(\cdot ,t))\in \mathbb {Y}_{+}\) for all \(t\in [0,t_{0})\) . Proof By calculation, we have $$\begin{aligned} \begin{aligned} S_{H}(x,t)&=S_{H,0}(x)e^{-\int _{0}^{t}(d_{1}+\mu (x) +\frac{\beta _{H}(x)b(x)}{N_{H}+m}I_{V}(x,u))du}+\int _{0}^{t}\left( d_{1} \int _{\Omega }{\mathcal {J}}(x-y)S_{H}(y,\tau )dy+\mu _{h}(x)N_{H}\right) \\&\quad \times e^{-\int _{\tau }^{t}(d_{1}+\mu (x)+\frac{\beta _{H}(x)b(x)}{N_{H}+m}I_{V}(x,u))du}d\tau ,\\ I_{H}(x,t)&=I_{H,0}(x)e^{-(d_{2}+\mu (x)+\gamma _{H}(x))t} +\int _{0}^{t}\left( d_{2}\int _{\Omega }{\mathcal {J}}(x-y)I_{H}(y,\tau )dy +\frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,\tau )I_{V}(x,\tau )\right) \\&\quad \times e^{-(d_{1}+\mu (x)+\gamma _{H}(x))(t-\tau )}d\tau , \end{aligned} \end{aligned}$$ (7) and $$\begin{aligned} \begin{aligned} S_{V}(x,t)&=S_{V,0}(x)e^{-\int _{0}^{t}(\nu (x) +\frac{\beta _{V}(x)b(x)}{N_{H}+m}I_{H}(x,u))du}+A\int _{0}^{t} e^{-\int _{\tau }^{t}(\nu (x)+\frac{\beta _{V}(x)b(x)}{N_{H}+m}I_{H}(x,u))du}d\tau ,\\ I_{V}(x,t)&= I_{V,0}(x)e^{-\nu (x)t}+\int _{0}^{t} \frac{\beta _{V}(x)b(x)}{N_{H}+m}S_{V}(x,\tau )I_{H}(x,\tau ) e^{-\nu (x)(t-\tau )}d\tau . \end{aligned} \end{aligned}$$ (8) For all \(t\in [0,t_{0})\) and \(x\in {\bar{\Omega }}\) . Due to \((S_{H,0},I_{H,0},S_{V,0}I_{V,0})\in \mathbb {Y}_{+}\) and \({\mathcal {J}}(x)\ge 0\) on R , it means \(S_{H}(x,t)\ge 0\) , \(I_{H}(x,t)\ge 0\) , \(S_{V}(x,t)\ge 0\) , and \(I_{V}(x,t)\ge 0\) , further, \(S_{H}(\cdot ,t)>0\) , \(I_{H}(\cdot ,t)>0\) , \(S_{V}(\cdot ,t)>0\) , and \(I_{V}(\cdot ,t)>0\) for \(t\in [0,t_{0})\) . \(\square \) Lemma 2.2 For any initial data \((S_{H,0},I_{H,0},S_{V,0},I_{V,0})\) and \(t\in [0,t_{0})\) , the solution \((S_{H}(x,t),I_{H}(x,t), S_{V}(x,t),I_{V}(x,t))\) of system ( 2 ) satisfy that $$\begin{aligned} \lim \sup _{t\rightarrow \infty }\int _{\Omega }[S_{H}(x,t)+ I_{H}(x,t)+S_{V}(x,t)+ I_{V}(x,t)]dx<\infty \end{aligned}$$ (9) Proof By ( 2 ) and ( 5 ), we have $$\begin{aligned} \begin{aligned}{}&\frac{d}{dt}\int _{\Omega }[S_{H}(x,t)+ I_{H}(x,t)+S_{V}(x,t)+ I_{V}(x,t)]dx\\&\quad =d_{1}\int _{\Omega }\int _{\Omega }{\mathcal {J}}(x-y)S_{H}(y,t)dydx-d_{1} \int _{\Omega }S_{H}(x,t)dx+\int _{\Omega }\mu _{h}(x)N_{H}dx-\int _{\Omega }\mu (x) S_{H}(x,t)dx\\&\quad \quad -\int _{\Omega }\frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t)dx +d_{2}\int _{\Omega }\int _{\Omega }{\mathcal {J}}(x-y)I_{H}(y,t)dydx-d_{2}\int _{\Omega }I_{H}(x,t)dx\\&\quad \quad + \int _{\Omega }\frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t)dx -\int _{\Omega }(\mu (x)+\gamma _{H}(x))I_{H}(x,t)dx\int _{\Omega }A(x)dx-\int _{\Omega }\nu (x) S_{V}(x,t)dx\\&\quad \quad -\int _{\Omega }\frac{\beta _{V}(x)b(x)}{N_{H}+m}S_{V}(x,t)I_{H}(x,t)dx +\int _{\Omega }\frac{\beta _{V}(x)b(x)}{N_{H}+m}S_{V}(x,t)I_{H}(x,t)dx-\int _{\Omega }\nu (x) I_{V}(x,t)dx\\&\quad = d_{1}\int _{\Omega }\int _{\Omega }{\mathcal {J}}(x-y)S_{H}(y,t)dydx -d_{1}\int _{\Omega }S_{H}(x,t)dx+\int _{\Omega }\mu _{h}(x)N_{H}dx -\int _{\Omega }\mu (x) S_{H}(x,t)dx\\&\quad \quad +d_{2}\int _{\Omega }\int _{\Omega }{\mathcal {J}}(x-y)I_{H}(y,t)dydx -d_{2}\int _{\Omega }I_{H}(x,t)dx-\int _{\Omega }(\mu (x)+\gamma _{H}(x))I_{H}(x,t)dx\\&\quad \quad +\int _{\Omega }A(x)dx-\int _{\Omega }\nu (x) S_{V}(x,t)dx-\int _{\Omega }\nu (x) I_{V}(x,t)dx. \end{aligned} \end{aligned}$$ Furthermore, we have $$\begin{aligned} \begin{aligned}{}&\frac{d}{dt}\int _{\Omega }[S_{H}(x,t)+ I_{H}(x,t)+S_{V}(x,t)+ I_{V}(x,t)]dx\\&\quad \le d_{1}\int _{\Omega }\int _{\Omega }{\mathcal {J}}(x-y)dyS_{H}(y,t)dx-d_{1} \int _{\Omega }S_{H}(x,t)dx+\int _{\Omega }\mu _{h}(x)N_{H}dx-\int _{\Omega }\mu (x) S_{H}(x,t)dx\\&\quad \quad +d_{2}\int _{\Omega }\int _{\Omega }{\mathcal {J}}(x-y)dyI_{H}(y,t)dx-d_{2} \int _{\Omega }I_{H}(x,t)dx-\int _{\Omega }(\mu (x)+\gamma _{H}(x))I_{H}(x,t)dx\\&\quad \quad +\int _{\Omega }A(x)dx-\int _{\Omega }\nu (x) S_{V}(x,t)dx-\int _{\Omega }\nu (x) I_{V}(x,t)dx\\&\quad \le ({\bar{\mu }}_{h}N_{H}+{\bar{A}})|\Omega |-\int _{\Omega }min\{{\underline{\mu }},{\underline{\nu }}\}( S_{H}(x,t)+I_{H}(x,t)+S_{V}(x,t)+ I_{V}(x,t))dx, \end{aligned} \end{aligned}$$ where \(|\Omega |\) denotes the volume of \(\Omega \) . By virtue of the variation of constants formula and take limit as \(t\rightarrow \infty \) , we can obtain that $$\begin{aligned} \lim \sup _{t\rightarrow \infty }\int _{\Omega }[S_{H}(x,t)+ I_{H}(x,t)+S_{V}(x,t)+ I_{V}(x,t)]dx\le \frac{({\bar{\mu }}_{h}N_{H}+{\bar{A}})|\Omega |}{min\{{\underline{\mu }},{\underline{\nu }}\}}. \end{aligned}$$ \(\square \) Basic reproduction number For a more abstract representation of the basic reproduction number, we utilize the next-generation matrix method 26 and evaluate the linearized equations surrounding the disease-free equilibrium \(E^{0}=({S_{H}^{0}(x),0,S_{V}^{0}(x),0})\) : $$\begin{aligned} {\left\{ \begin{array}{ll} \frac{\partial I_{H}}{\partial t}=d_{2}\int _{\Omega }{\mathcal {J}} (x-y)I_{H}(y,t)dy-d_{2}I_{H}(x,t)+\frac{\beta _{H}(x)b(x)}{ N_{H}+m}S_{H}^{0}(x)I_{V}(x,t)-(\mu (x)+\gamma _{H}(x))I_{H}(x,t), \\ \frac{\partial I_{V}}{\partial t}=\frac{\beta _{V}(x)b(x)}{N_{H}+m} S_{V}^{0}(x)I_{H}(x,t)-\nu (x) I_{V}(x,t),\\ x\in {\bar{\Omega }},~~t>0. \\ \end{array}\right. } \end{aligned}$$ (10) System ( 10 ) be equivalent to $$\begin{aligned} \frac{\partial \eta }{\partial t}=B\eta -D\eta +G\eta ,~~x\in \Omega ,t>0, \end{aligned}$$ where $$\begin{aligned} \eta =\left( {\begin{array}{*{10}{l}} I_{H}\\ I_{V}\\ \end{array}}\right) ,~~ B=\left( {\begin{array}{*{10}{c}} &{}d_{2}\int _{\Omega }{\mathcal {J}}(x-y)dy~~~~~&{}0\\ &{}0~~~~~&{}0\\ \end{array}}\right) , \end{aligned}$$ and $$\begin{aligned} D=\left( {\begin{array}{*{10}{c}} \gamma _{H}+\mu +d_{2}~~~~0\\ 0~~~~~~~~~~~~~~~~~~~~\nu \\ \end{array}}\right) ~~ G=\left( {\begin{array}{*{10}{c}} 0~~~~~~~~~~~~\frac{\beta _{H}b}{N_{H}+m}S^{0}_{H}\\ \frac{\beta _{V}b}{N_{H}+m}S^{0}_{V}~~~~~~~~~~~~0\\ \end{array}}\right) . \end{aligned}$$ By virtue of 27 , Chapter 11, we obtain that the following linear equation $$\begin{aligned} \frac{\partial \eta }{\partial t}=(B-D)\eta ,~~x\in \Omega ,t>0. \end{aligned}$$ (11) Let T ( t ) be the solution semigroup with respect to the linear Eq. ( 11 ). Define $$\begin{aligned} \mathbb {K}(\vartheta )(x):=\int _{0}^{\infty }G[T(t)(\vartheta )](x)dt. \end{aligned}$$ In terms of the next infection operator, the spectral radius of \(\mathbb {K}\) can be defined as the basic reproduction number $$\begin{aligned} R_{0}:=r(\mathbb {K}). \end{aligned}$$ We consider the following eigenvalue problem with respect to system ( 10 ). $$\begin{aligned} {\left\{ \begin{array}{ll} \lambda \Phi (x)=d_{2}\int _{\Omega }{\mathcal {J}}(x-y) \Phi (y)dy-d_{2}\Phi (x)+\frac{\beta _{H}(x)b(x)}{N_{H}+m} S_{H}^{0}(x)\Psi (x)-(\mu (x)+\gamma _{H}(x))\Phi (x), \\ \lambda \Psi (x)=\frac{\beta _{V}(x)b(x)}{N_{H}+m}S_{V}^{0} (x)\Phi (x)-\nu (x) \Psi (x)).\\ \end{array}\right. } \end{aligned}$$ (12) Meanwhile, by virtue of 28 , for system ( 12 ), there exists a principal eigenvalue \(\lambda _{0}\) with respect to a pair positive continuous eigenfunction \((\Phi _{0}(x),\Psi _{0}(x))\) satisfy that the following lemma. Lemma 2.3 \(sign(R_{0}-1 ) = sign \lambda _{0}\) . Proof The proof procedure can be referred to reference 14 , Theorem 2.10. \(\square \) Global stability and uniform persistence Global stability of the disease-free equilibrium Global stability of the disease-free equilibrium is to be demonstrated. Before proving its global asymptotic stability, certain lemmas are presented. Additionally, we investigate an eigenvalue problem previously examined Garc \(\acute{i}\) a-Meli \(\acute{a}\) n and Rossi 13 . $$\left\{ {\begin{array}{*{20}l} {\int _{R^{N}}{\mathcal {J}}(x-y)(\varrho (y)-\varrho (x))dy =-\lambda _{e}\varrho (x),} \hfill & {in~\;\Omega ,} \hfill \\ {\varrho (x)=0,} \hfill & {on\;~R^{N} { \setminus }\Omega ,} \hfill \\ \end{array} } \right. $$ (13) Lemma 3.1 For system ( 13 ), there exists a unique principal eigenvalue \(\lambda _{1}\) correspond to eigenfunction \(\varrho (x)\) . Furthermore, \(0<\lambda _{1}<1\) and $$\begin{aligned} \lambda _{1}=\inf _{\varrho \in L^{2}(\Omega ),\varrho \ne 0}\frac{\int _{\Omega }\varrho ^{2}(x)dx -\int _{\Omega }\int _{\Omega }{\mathcal {J}}(x-y)\varrho (y)\varrho (x)dydx}{\int _{\Omega }\varrho ^{2}(x)}. \end{aligned}$$ Now, we have the following global stability result. Theorem 3.1 If \(R_{0}<1\) , the solution \((S_{H}(x,t),I_{H}(x,t),S_{V}(x,t)I_{V}(x,t))\) of system ( 2 ) converge to the disease-free equilibrium \(({S_{H}^{0}(x),0,S_{V}^{0}(x),0})\) on x as \(t\rightarrow +\infty \) . Proof We first prove that \(S_{H}(x,t)\rightarrow S_{H}^{0}(x)\) on x as \(t\rightarrow +\infty \) , let \(h_{1}(x,t)=S_{H}(x,t)-S_{H}^{0}(x)\) . Furthermore, we have $$\begin{aligned} \frac{\partial h_{1}(x,t)}{\partial t}=d_{1}\int _{\Omega }{\mathcal {J}}(x-y)h_{1}(y,t)dy-d_{1}h_{1}(x,t)-\mu (x) h_{1}(x,t)-\frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t),~x\in \Omega . \end{aligned}$$ (14) Let \(H(t)=\int _{\Omega }h_{1}^{2}(x,t)dx\) , we can obtain $$\begin{aligned} \begin{aligned}{}&\frac{dH(t)}{dt}\\&\quad =2\int _{\Omega }h_{1}(x,t)\frac{\partial h_{1}(x,t)}{\partial t}dx\\&\quad = 2\int _{\Omega }h_{1}(x,t)\left\{ d_{1}\int _{\Omega }{\mathcal {J}}(x-y) h_{1}(y,t)dy-d_{1}h_{1}(x,t)-\mu (x) h_{1}(x,t)-\frac{\beta _{H}(x) b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t)\right\} dx\\&\quad = 2\left\{ d_{1}\int _{\Omega }\int _{\Omega }{\mathcal {J}}(x-y)h_{1}(y,t) h_{1}(x,t)dydx-\int _{\Omega }h_{1}^{2}(x,t)dx\right\} \\&\quad \quad -2\int _{\Omega }\left\{ \mu (x) h_{1}(x,t)+\frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t)\right\} h_{1}(x,t)dx\\&\quad \le -2d_{1}\lambda _{1}H(t). \end{aligned} \end{aligned}$$ (15) By calculation yields that $$\begin{aligned} H(t)\le c_{0}e^{-2d_{1}\lambda _{1}t}. \end{aligned}$$ Hence, there exists constant \(c_{0}\) , we have $$\begin{aligned} \Vert h_{1}(\cdot ,t)\Vert _{L^{2}(\Omega )}\le c_{0}e^{-d_{1}\lambda _{1}t}. \end{aligned}$$ By virtue of Eq. ( 14 ), we can obtain $$\begin{aligned} h_{1}(x,t)=h_{0}(x)e^{-(d_{1}+\mu (x))t}+e^{-(d_{1} +\mu (x))t}\int _{0}^{t}e^{d_{1}s}\left( d_{1}\int _{\Omega }{\mathcal {J}} (x-y)h_{1}(y,s)dy-\frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t)\right) ds. \end{aligned}$$ (16) Applying the h \(\ddot{o}\) lder inequality to the following equation, there exists some positive constant satisfy that $$\begin{aligned} \int _{\Omega }J(x-y)h_{1}(y,s)dy\le C\Vert h_{1}(\cdot ,s)\Vert _{L^{2}(\Omega )}. \end{aligned}$$ (17) Combine ( 16 ) and ( 17 ), there exists some positive constants \(c_{i}(i=1,2)\) we have $$\begin{aligned} |h_{1}(x,t)|\le c_{1}e^{-(d_{1}+\mu (x))t}+c_{2}e^{-(d_{1}+\mu (x))\lambda _{1}t}. \end{aligned}$$ Hence, as \(t\rightarrow \infty \) , \(h_{1}(x,t)\rightarrow 0\) uniformly on \(x\in \Omega \) . Furthermore, we obtain that \(S_{H}(x,t)\rightarrow S_{H}^{0}(x)\) . Next, we prove \(I_{H}(x,t)\rightarrow 0\) , let \(V_{1}(t):=\int _{\Omega }I^{2}_{H}(x,t)dx\) , we obtain that $$\begin{aligned} \begin{aligned} \frac{dV_{1}(t)}{dt}&=\int _{\Omega }2I_{H}(x,t)\frac{\partial }{\partial t}I_{H}(x,t)dx\\&=\int _{\Omega }2I_{H}(x,t)\left\{ d_{2}\int _{\Omega }{\mathcal {J}} (x-y)I_{H}(y,t)dy-d_{2}I_{H}(x,t)+\frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t) \right. \\&\quad -\left. (\mu (x)+\gamma _{H}(x))I_{H}(x,t)\right\} dx\\&=2d_{2}\left\{ \int _{\Omega }\int _{\Omega }{\mathcal {J}}(x-y)I_{H}(y,t) I_{H}(x,t)dydx-\int _{\Omega }I^{2}_{H}(x,t)dx \right\} +2\int _{\Omega } \left\{ \frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t) \right. \\&\quad -(\mu (x)+\gamma _{H}(x))I_{H}(x,t)\}I_{H}(x,t)dx\\ \end{aligned} \end{aligned}$$ (18) Due to \(\beta _{H},b,\mu \in C({\bar{\Omega }})\) , by virtue of the above argument, there exists some positive constant \(c_{0}>0\) satisfy that $$\begin{aligned} \left| \frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t)-(\mu (x)+\gamma _{H}(x))I_{H}(x,t) \right| \le c_{0}e^{\lambda _{0}t}. \end{aligned}$$ Hence, equation ( 18 ) be equivalent to $$\begin{aligned} \frac{dV_{1}(t)}{dt}\le -2d_{2}\lambda _{1}V_{1}(t)+2c_{0}|\Omega |^{\frac{1}{2}}e^{\lambda _{0}t}V_{1}^{\frac{1}{2}}(t). \end{aligned}$$ By calculation yields that $$\begin{aligned} V_{1}(t)\le \left\{ \begin{aligned}{}&\left( V_{1}^{\frac{1}{2}}(0)+c_{0}|\Omega |^{\frac{1}{2}}t\right) ^{2}e^{-2d_{2}\lambda _{1}t}, ~ if~\lambda _{0}+d_{2}\lambda _{1}=0,\\&\left( \frac{c_{0}|\Omega |^{\frac{1}{2}}}{\lambda _{0}+d_{2}\lambda _{1}}e^{\lambda _{0}t}+\left( V_{1}^{\frac{1}{2}}(0)+\frac{c_{0}|\Omega |^{\frac{1}{2}}}{\lambda _{0}+d_{1}\lambda _{1}}\right) e^{-d_{1}\lambda _{1}t}\right) ^{2}, ~ if~ \lambda _{0}+d_{2}\lambda _{1}\ne 0.\\ \end{aligned} \right. \end{aligned}$$ Hence, for some positive constants \(k_{i}(i=1,2,3,4)\) , we have $$\begin{aligned} \Vert I_{H}(\cdot ,t)\Vert _{L^{2}(\Omega )}\le \left\{ \begin{aligned}{}&(k_{1}+k_{2}t)e^{-d_{2}\lambda _{1}t}, ~ if~\lambda _{0}+d_{2}\lambda _{1}=0,\\&k_{3}e^{\lambda _{0}t}+k_{4}e^{-d_{2}\lambda _{1}t}, ~ if~ \lambda _{0}+d_{2}\lambda _{1}\ne 0.\\ \end{aligned} \right. \end{aligned}$$ By virtue of system ( 2 ), we can obtain $$\begin{aligned} \begin{aligned} I_{H}(x,t)&=I_{H,0}(x)e^{-d_{2}t}+e^{-d_{2}t}\int _{0}^{t}e^{d_{2}s}(d_{2}\int _{\Omega }{\mathcal {J}}(x-y)I_{H}(y,s)dy\\&\quad +\frac{\beta _{H}(x)b(x)}{N_{H}+m}S_{H}(x,t)I_{V}(x,t)-(\mu (x)+\gamma _{H}(x))I_{H}(x,t))ds. \end{aligned} \end{aligned}$$ (19) Applying the h \(\ddot{o}\) lder inequality to the following equation, there exists some positive constant satisfy that $$\begin{aligned} \int _{\Omega }{\mathcal {J}}(x-y)I_{H}(y,s)dy\le C\Vert I_{H}(\cdot ,s)\Vert _{L^{2}(\Omega )}. \end{aligned}$$ (20) Combine ( 19 ) and ( 20 ), there exists some positive constants \({\tilde{k}}_{i}(i=1,2,3,4)\) we have $$\begin{aligned} |I_{H}(x,t)|\le \left\{ \begin{aligned}{}&{\tilde{k}}_{1}e^{-d_{2}t}+({\tilde{k}}_{2}+{\tilde{k}}_{3}t)e^{-d_{2}\lambda _{1}t}+{\tilde{k}}_{4}e^{\lambda _{0}t}, ~ if~\lambda _{0}+d_{2}\lambda _{1}=0,\\&{\tilde{k}}_{5}e^{-d_{2}t}+{\tilde{k}}_{6}e^{\lambda _{0}t}+{\tilde{k}}_{7}e^{-d_{2}\lambda _{1}t}, ~ if~ \lambda _{0}+d_{2}\lambda _{1}\ne 0.\\ \end{aligned} \right. \end{aligned}$$ Since \(R_{0}<1\) , we know that \(\lambda _{0}<0\) , hence, as \(t\rightarrow \infty \) , \(I_{H}(x,t)\rightarrow 0\) uniformly on \(x\in \Omega \) . Moreover, we prove that \(S_{V}(x,t)\rightarrow S_{V}^{0}(x)\) on x as \(t\rightarrow +\infty \) , let \(h_{2}(x,t)=S_{V}(x,t)-S_{V}^{0}(x)\) , then, we have $$\begin{aligned} \frac{\partial h_{2}(x,t)}{\partial t}=-\nu (x) h_{2}(x,t)-\frac{\beta _{V}(x)b(x)}{N_{H}+m}S_{V}(x,t)I_{H}(x,t),~x\in \Omega . \end{aligned}$$ (21) Due to \(I_{H}(x,t)\rightarrow 0\) as \(t\rightarrow \infty \) , by virtue of the above argument, we know that \(h_{2}(x,t)\rightarrow 0\) as \(t\rightarrow \infty \) . using the the constant variation method with respect to the last equation of ( 2 ), we can obtain that \(I_{V}(x,t)\rightarrow 0\) as \(t\rightarrow \infty \) . \(\square \) Uniform persistence In this section, we consider the uniform persistence of system ( 2 ). To get these goals, we first consider the following problem. Theorem 3.2 For \(R_{0}>1\) , then there exists a function \(\Gamma (x)\) , such that $$\begin{aligned} \begin{aligned}{}&\lim _{t\rightarrow \infty }infS_{H}(x,t)\ge \Gamma (x), \lim _{t\rightarrow \infty }infI_{H}(x,t)\ge \Gamma (x),\\&\lim _{t\rightarrow \infty }infS_{V}(x,t)\ge \Gamma (x), \lim _{t\rightarrow \infty } infI_{V}(x,t)\ge \Gamma (x), \end{aligned} \end{aligned}$$ hence, the disease uniform persistence. Proof Due to \(R_{0}>1\) , then, there exists a \(\kappa >0\) such that \(\lambda (S^{*}_{H}-\kappa ,S^{*}_{V}-\kappa )>0\) (where \((S^{*}_{H},I^{*}_{H},S^{*}_{V},I^{*}_{V})\) represents that the endemic equilibrium ). It means that there exists a \({\widetilde{t}}_{1}>0\) satisfy that \(S_{H}(x,t)>S_{H,0}-\kappa \) and \(S_{V}(x,t)>S_{V,0}-\kappa \) for \(t\ge {\widetilde{t}}_{1}\) and \(x\in {\overline{\Omega }}\) . For \(x\in \Omega ,~~t>{\widetilde{t}}_{1}\) , according to the comparison principle, we can obtain $$\begin{aligned} {\left\{ \begin{array}{ll} \frac{\partial I_{H}}{\partial t}\ge d_{2}\int _{\Omega }{\mathcal {J}} (x-y)I_{H}(y,t)dy-d_{2}I_{H}(x,t)+\frac{\beta _{H}b}{N_{H}+m}(S_{H,0}-\kappa )I_{V}(x,t)-(kN_{H}+\mu +\gamma _{H})I_{H}(x,t), \\ \frac{\partial I_{V}}{\partial t}\ge \frac{\beta _{V}b}{N_{H}+m} (S_{V,0}-\kappa )(x,t)I_{H}(x,t)-\nu I_{V}(x,t). \\ \end{array}\right. } \end{aligned}$$ Define \(({\widetilde{I}}_{H}(x,t),{\widetilde{I}}_{V}(x,t),)=(Me^{{\widetilde{\lambda }}t}{\widetilde{\varrho }}_{1}(x),Me^{{\widetilde{\lambda }}t}{\widetilde{\varrho }}_{2}(x))\) , \(({\widetilde{I}}_{H}(x,t),{\widetilde{I}}_{V}(x,t),)\) satisfy that the following equation $$\begin{aligned} {\left\{ \begin{array}{ll} \frac{\partial {\widetilde{I}}_{H}}{\partial t}=d_{2}\int _{\Omega } {\mathcal {J}}(x-y){\widetilde{I}}_{H}(y,t)dy-d_{2}{\widetilde{I}}_{H}(x,t) +\frac{\beta _{H}b}{N_{H}+m}(S_{H,0}-\kappa ){\widetilde{I}}_{V}(x,t)-(kN_{H}+\mu +\gamma _{H}){\widetilde{I}}_{H}(x,t), \\ \frac{\partial {\widetilde{I}}_{V}}{\partial t}= \frac{\beta _{V}b}{N_{H}+m} (S_{V,0}-\kappa )(x,t){\widetilde{I}}_{H}(x,t)-\nu {\widetilde{I}}_{V}(x,t), \\ \end{array}\right. } \end{aligned}$$ where \(({\widetilde{\varrho }}_{1}(x),{\widetilde{\varrho }}_{2}(x))\) is the eigenfunction with respect to \({\widetilde{\lambda }}<0\) . According to the comparison principle, we know \(I_{H}(x,t)\ge {\widetilde{I}}_{H}(x,t)\) , \(I_{V}(x,t)\ge {\widetilde{I}}_{V}(x,t)\) for \(x\in \Omega ,t>{\widetilde{t}}_{1}\) . Therefore, \(I_{H}(x,t)\ge Me^{{\widetilde{\lambda }}t}{\widetilde{\varrho }}_{1}(x)\) , \(I_{V}(x,t)\ge Me^{{\widetilde{\lambda }}t}{\widetilde{\varrho }}_{2}(x)\) such that $$\begin{aligned} \lim _{t\rightarrow \infty }infI_{H}(x,t)\ge M{\widetilde{\varrho }}_{1}(x),~ \lim _{t\rightarrow \infty }infI_{V}(x,t)\ge M{\widetilde{\varrho }}_{2}(x). \end{aligned}$$ On the basis of the Lemma ( 2.2 ), we know that there exists a constants \(K>0\) and \({\widetilde{t}}_{2}\) such that $$\begin{aligned} I_{V}(x,t)\le K,~I_{H}(x,t)\le K,~t\ge {\widetilde{t}}_{2},~x\in {\overline{\Omega }}. \end{aligned}$$ Then, \(S_{H}\) and \(S_{V}\) satisfy that the following equation $$\begin{aligned} {\left\{ \begin{array}{ll} \frac{\partial S_{H}}{\partial t}\ge d_{1}\int _{\Omega }{\mathcal {J}}(x-y)S_{H}(y,t)dy-d_{1}S_{H}(x,t)+\mu _{h}N_{H}-\left( \mu kN_{H}+\frac{\beta _{H}bK}{N_{H}+m}\right) S_{H}(x,t),~~~~~~x\in \Omega ,t>{\widetilde{t}}_{2},\\ \frac{\partial S_{V}}{\partial t}\ge A-\left( \nu +\frac{\beta _{V}bK}{N_{H}+m}\right) S_{V}(x,t),~~~~~~~~~~~~~~~~~~~x\in \Omega ,t>{\widetilde{t}}_{2}.\\ \end{array}\right. } \end{aligned}$$ Hence $$\begin{aligned} \begin{aligned}{}&\lim _{t\rightarrow \infty }infS_{H}(x,t)\ge (d_{1}K+\mu _{h}N_{H})/\left( d_{1}+\mu kN_{H}+\frac{\beta _{H}bK}{N_{H}+m}\right) ,\\&\lim _{t\rightarrow \infty }infS_{V}(x,t)\ge A/\left( \nu +\frac{\beta _{V}bK}{N_{H}+m}\right) . \end{aligned} \end{aligned}$$ Let \(\Gamma (x):=min\{(d_{1}K+\mu _{h}N_{H})/(d_{1}+\mu kN_{H}+\frac{\beta _{H}bK}{N_{H}+m}),~A/(\nu +\frac{\beta _{V}bK}{N_{H}+m}),~M{\widetilde{\varrho }}_{1}(x),~M{\widetilde{\varrho }}_{2}(x)\}\) . The disease uniform persistence is obtained. \(\square \) Numerical simulations This section presents the theoretical results supported by numerical simulations are presented in this section. The parameter values and initial value are chosen as follows: Table 2 The parameter values. Full size table initial value: $$\begin{aligned} (S_{H,0}(x),I_{H,0}(x),S_{V,0}(x),I_{V,0}(x))= \left( 5+cos\frac{\pi x}{2},1.01+sin\frac{\pi x}{2},2+cos\frac{\pi x}{2},0.95+sin\frac{x}{2} \right) . \end{aligned}$$ Moreover, the nonlocal kernel function 23 is selected as follows: $$\begin{aligned} {\mathcal {J}}(x)= \left\{ \begin{aligned}{}&B exp\left( \frac{1}{x^{2}-1}\right) , ~ -1<x<1,\\&0, ~ otherwise.\\ \end{aligned} \right. \end{aligned}$$ Here, \(B=2.6423\) , \(x\in [-1,1]\subset R\) and \(\int _{R}{\mathcal {J}}(x)dx=\int _{-1}^{1}{\mathcal {J}}(x)dx\approx 1.\) See Fig. 1 for the evolution path of kernel function J ( x ). Figure 1 The evolution path of kernel function J ( x ). Full size image Global dynamics of system ( 2 ) In this section, we choose to change \(\beta _{H}\) to illustrate the result of the theorem. Let \(\beta _{H}=0.015(1-0.65cosx)\) and see Table 2 for other parameters, then \(R_{0}=0.949319338848686<1\) . Figure 2 illustrates the long-term dynamic behavior of the system ( 2 ). As time t approaches infinity, the density of infected humans and mosquitoes both converge to 0, indicating the extinction of the disease. If the human transmission rate \(\beta _{H}\) increases to \(10\beta _{H}\) , we can obtain \(R_0=3.002011337607015>1\) . At this point, Fig. 3 shows that the solution of system ( 2 ) eventually stabilizes, implying disease persistence. Figure 2 The evolution path of \(S_{H}, I_{H}, S_{V}, I_{V}\) for system ( 2 ) with \(R_0=0.949319338848686<1\) . Full size image Figure 3 The evolution path of \(S_{H}, I_{H}, S_{V}, I_{V}\) for system ( 2 ) with \(R_0=3.002011337607015>1\) . Full size image The impacts of diffusion rate for infected humans and infected mosquitoes After the disease has gone extinct, the spread of humans and mosquitoes no longer affects its transmission. Thus, in this section we focus solely on the impact of diffusion on disease persistence, specifically on infected humans and mosquitoes. Figures 4 , 5 , and 6 reveal that increasing the diffusion coefficient reduces the infected area, but accentuates the spatial difference between infected humans and mosquitoes. This enhances disease persistence and disease control. Therefore, in the event of an outbreak, we recommend implementing appropriate measures to reduce the spread of humans and mosquitoes for more effective disease management. Figure 4 Numerical simulation of \(I_{H},I_{V}\) for system ( 2 ) with \(d_1=d_2=0.015\) (where \(R_0=3.002011337607015>1\) ). Left: The evolution path of \(I_{H},I_{V}\) . Right: The distribution of \(I_{H},I_{V}\) in time and space. Full size image Figure 5 Numerical simulation of \(I_{H},I_{V}\) for system ( 2 ) with \(d_1=d_2=0.030\) (where \(R_0=2.986675318735982>1\) ). Left: The evolution path of \(I_{H},I_{V}\) . Right: The distribution of \(I_{H},I_{V}\) in time and space. Full size image Figure 6 Numerical simulation of \(I_{H},I_{V}\) for system ( 2 ) with \(d_1=d_2=0.060\) (where \(R_0=2.956695436468467>1\) ). Left: The evolution path of \(I_{H},I_{V}\) . Right: The distribution of \(I_{H},I_{V}\) in time and space. Full size image Conclusions We conducted research on the threshold dynamics of a nonlocal diffusion dengue model with spatial heterogeneity. To establish the existence, uniqueness, positivity, and boundedness of the solution, we utilized the semigroup theory and the variation of constants formula. The expression of the basic reproduction number was abstractly determined using the next-generation matrix method. By constructing a Lyapunov function and applying the comparison principle, we proved the system’s global stability and uniform persistence. Numerical simulations were performed to verify the theorem. This study explored the evolution of disease extinction and persistence by adjusting the human transmission rate \(\beta _{H}\) . We also considered the impact of diffusion on infected humans and mosquitoes. The simulation results indicate that an increase in the diffusion coefficient leads to greater persistence of the disease in both humans and mosquitoes. This finding highlights the importance of controlling the spread of humans and mosquitoes during disease outbreaks. To achieve better disease control, we recommend implementing appropriate measures to reduce their transmission. Additionally, we only researched on the threshold dynamics of a nonlocal diffusion dengue model. However, the transmission of dengue fever virus can also be affected by random factors, such as Lévy noise, Markov switching, etc. Therefore, it is interesting to introduce random noise into the nonlocal diffusion dengue fever model, at the same time, we will combine the stochastic nonstandard finite difference technique 29 , 30 to make numerical calculations. Moreover, we note that the fractional derivative has been widely used in epidemiological studies 31 , 32 , 33 , 34 due to its physical significance as a memory index. But in fact, for the model of nonlocal diffusion, since the nonlocal diffusion term is difficult to deal with, so we have not seen relevant research work. Next, we try to study the fractional order nonlocal diffusion dengue model.